Did New KEYTRUDA Approvals Just Shift Merck’s (MRK) Post-Patent Oncology Investment Narrative?

Original source ↗ | February 17, 2026 at 19:14 UTC | Finnhub - MRK

No analysis available.

Ticker	Direction	Speaker	Thesis	Time
MRK	NONE	Finnhub News	—	—